Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Commit $7.5M for Alcoholism Risk Genetics Project

NEW YORK (GenomeWeb News) – The National Institute on Alcohol Abuse and Alcoholism plans to use $7.5 million this fiscal year to fund research into the genetic and biological basis of alcoholism, with the aim of identifying better and more personalized ways to treat the disorder.

The funding will provide a cooperative agreement to investigators who are currently funded under an existing, long-term NIAAA-supported project, the Collaborative Study of the Genetics of Alcoholism (COGA), the National Institutes of Health said on Friday.

The ultimate goal of the COGA program, a multi-site, multidisciplinary effort which launched 25 years ago, is to identify genes involved in alcohol dependence and then to understand how these genes have functional influences on expression at the molecular and cellular level.

Scientists will use this new funding to pursue several goals, including identifying genetic variants that affect susceptibility to alcohol dependence; determining the molecular and functional mechanisms of those variants; identifying and characterizing the mixtures of genetic and environmental interactions that could lead to alcoholism; and performing prospective studies of groups that are relevant to the COGA program.

Investigators receiving the funding may pursue a range of research questions and approaches within the main goals of the program, such as seeking to advance knowledge about complex phenotypes and alcohol and treatment-related genes and variants; using an array of genomic technologies such as genome sequencing and genotyping to identify more genes involved in alcoholism; exploring the potential mechanism of action of important genes by studying gene expression, splicing, and DNA methylation, among others; and examining the effects of genes and environmental influences on clinical and neurophysiological phenotypes that are related to alcoholism risk.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.